. Alzheimer's disease mutations in APP but not γ-secretase modulators affect epsilon-cleavage-dependent AICD production. Nat Commun. 2013;4:2246. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on this content

  1. The finding of a decrease in the AICD 49-99/50-99 ratio due to APP mutations near the γ- or ε-site is intriguing, and may partly answer why these mutations increase the Aβ 42/40 ratio if the step-wise cleavage hypothesis is correct.

    That GSMs have no effect on the epsilon cleavage is a common knowledge. GSM-1 has been proposed to bind to presenilin rather than APP, resulting in the conformation change in the pore of γ -secretase, which may explain the present finding that GSM-1 works regardless of having FAD mutations in APP. I am curious whether these findings will be reproduced in the cellular or even in vivo studies because a cell-free system with exogenous APP is somewhat artificial and sometimes shows different phenotypes from that observed in the cellular system.

This paper appears in the following:

News

  1. More Evidence that γ-Secretase Modulators Spare Essential Substrates